Treatment

Rethinking Diets in Atopic Dermatitis: Insights for Better Management

A recent survey of nearly 300 parents of children with atopic dermatitis (AD) found that while 42% identified food triggers for their child’s condition, elimination…
CURATED BY: Kristine Kucera,
PA-C, MPAS, DHS

Patient Management Guidelines

Articles

Portrait of young man showing skin rash to doctor during consultation in dermatology clinic

Navigating Atopic Dermatitis: Evolving Treatments and the Path Toward Personalized Care

Atopic dermatitis (AD) is a chronic inflammatory skin condition affecting a significant portion of children and adults, with prevalence varying...
CURATED BY:
Andrew Baker,
PA-C, MBA
Organic cosmetic products on green leaves as background, top view. Natural eco beauty and organic vegan plant based skin care concept.

Plant-Based Therapy Shows Promise in Reducing Itch and Improving Quality of Life in Atopic Dermatitis

Zabalafin hydrogel (AB-101a), a novel plant-based therapeutic, has shown promising interim results for treating atopic dermatitis (AD) in both pediatric...
CURATED BY:
Kristine Kucera,
PA-C, MPAS, DHS

Study Shows Dupilumab Reduces Risk of Atopic March Progression in Pediatric Patients With Atopic Dermatitis

Researchers of a study found that dupilumab treatment significantly reduces the risk of atopic march progression in pediatric and adolescent...
CURATED BY:
Kristine Kucera,
PA-C, MPAS, DHS

Decade of Atopic Dermatitis Research Highlights Advances and Gaps in Treatment and Prevention

Dermatology Times highlighted significant research in atopic dermatitis (AD) over the past decade. Researchers Peter Arkwright and Jennifer Koplin reviewed...
CURATED BY:
Andrew Baker,
PA-C, MBA

Dupilumab Significantly Lowers Atopic March Risk in Pediatric Patients With Atopic Dermatitis

A study found that dupilumab treatment significantly reduces the risk of atopic march progression in pediatric and adolescent patients with...
CURATED BY:
Kristine Kucera,
PA-C, MPAS, DHS

Dupilumab Shows Promise for Treating Atopic Hand and Foot Dermatitis in Phase 3 Trial

Systemic treatment options for patients with atopic hand and/or foot dermatitis (H/F AD) are limited despite the high disease burden....
CURATED BY:
Kristine Kucera,
PA-C, MPAS, DHS
Share